在严重喘中个性化医疗:从生物标志物到生物制剂
Chun-Yu Chen1,2, Kang-Hsi Wu3,4, Bei-Cyuan Guo5
1Department of Emergency Medicine, Tungs' Taichung Metro Harbor Hospital, Taichung 435403, Taiwan.
个性化医学通过向特定的炎症途径,改变了严重喘的治疗方法. 生物制剂和生物标志物改善了2型炎症患者的治疗结果,提高了生活质量.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘涉及慢性呼吸道炎症,传统上通过以症状为重点的治疗来管理.
- 最近的进展确定了不同的喘表型和内型,特别是那些由2型 (T2) 炎症驱动的.
- 转向个性化医疗的范式转变正在提高治疗疗效.
研究的目的:
- 审查当前用于严重喘管理的生物药物和生物标志物.
- 突出准确医学在根据个体病理生物学定制治疗中的作用.
- 讨论表型/内型特定方法对治疗结果的影响.
主要方法:
- 审查针对T2炎症的已批准的生物疗法 (例如,抗IgE,抗IL-5,抗TSLP/IL-4).
- 对严重喘的生物标志物引导治疗策略的分析.
- 关于严重喘病原和治疗进展的全面文献搜索.
主要成果:
- 生物疗法有效地减少了恶化,乙氨基酸细胞数量和口服皮质类固醇依赖.
- 这些治疗方法可以改善选择的严重喘患者的肺功能和患者的生活质量.
- 针对T2高喘的个性化方法显示出显著的临床益处.
结论:
- 严重喘管理正在通过新的生物疗法和精准医学发展.
- 现型/内型特定的策略正在取代通用干预.
- 了解病理生物学和利用生物标志物是优化严重喘护理的关键.
更多相关视频
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
相关概念视频
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
